Brief: China SXT Pharmaceuticals Inc Receives Nasdaq Notification Letter Regarding Bid Price Deficiency
16/12/2021 13:18
Dec 16 (Reuters) - China SXT Pharmaceuticals Inc SXTC.O :
* CHINA SXT PHARMACEUTICALS, INC. RECEIVED NASDAQ
NOTIFICATION
LETTER REGARDING BID PRICE DEFICIENCY
* CHINA SXT PHARMACEUTICALS INC - UNDER NASDAQ LISTING
RULES,
COMPANY HAS UNTIL JUNE 13, 2022, TO REGAIN COMPLIANCE
Source text for Eikon: ID:nPnbwcbwMa
Further company coverage: SXTC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China SXT Pharmaceuticals
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Univest Securities, Llc Announces Closing Of $9 Million Registered Direct Offering For Its Client China Sxt Pharmaceuticals Inc. (Nasdaq Sxtc)